Portugal – Endocrine therapy medicinal products – 2024/0961 - LANREOTIDA [120 MG/488 MG; SERINGA]
Tender Description
LANREOTIDA [120 MG/488 MG; SERINGA]
Unlock Full Tender Insight
Complete details, deadlines, and AI-powered analysis are available inside the tend.ee platform. Create your free account to access.
It's free to get started. No credit card required.
